Use of Non-IVIG Therapy for 4811 Patients With KD
| n (%) | |
|---|---|
| Antiinflammatory therapy | |
| Methylprednisolone | 278 (5.8) |
| Orally administered prednisone and prednisolone | 133 (2.8) |
| Infliximab | 48 (1.0) |
| Antithrombotic therapy | |
| Aspirin | 4429 (92.1) |
| Heparin | 2004 (41.7) |
| Warfarin | 54 (1.1) |
| Enoxaparin | 49 (1.0) |
| Tissue plasminogen activator | 33 (0.7) |
| Clopidogrel | 16 (0.3) |
| Abciximab | 10 (0.2) |